A dog just outperformed most cancer screening tests you've heard of.
No blood draw. No scan. No needle.
Just… a breath.
Meet Dognosis, a Bengaluru startup that pairs trained sniffer dogs with AI to catch cancer early — and the numbers are turning heads.
Turns out, yes.
Cancer cells release volatile organic compounds — invisible chemical traces that change the way breath smells.
Dogs' noses are 10,000 times more sensitive than ours. They've been picking up on this for years in small studies.
Dognosis just scaled it into a real, testable product.
No more relying on a dog's mood or a handler's read of a tail wag. The AI turns instinct into a score.
1,502 participants.
Six hospitals across India.
90% accuracy — 90% sensitivity, 90% specificity.
Translation: out of 100 people with cancer, it correctly flags about 90. Out of 100 people without it, it correctly clears about 90.
That's in the same ballpark as several imaging-based tests — minus the machines, the radiation, and the price tag.
Cancer in India is often caught late. Rural and semi-urban patients frequently don't have easy access to CT scans, biopsies, or specialist hospitals.
A mask, a lab, and a dog change that math.
👉 Cheaper.
👉 Non-invasive.
👉 Deployable in far more clinical settings than an MRI machine ever could be.
This isn't a novelty act. It's a serious attempt to make early cancer screening boring — as routine as a blood pressure check.
Dognosis's product, built around this canine-AI pipeline, is already positioning itself as a first-line screening tool, not a replacement for diagnosis — a filter that tells you who needs the expensive test next.
Sometimes the smartest sensor in the room… has four legs and a wet nose.
That's all for now!
